Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up

References

• Edith L, Gianluca E, Emanuela P, et al. Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. Scand J Gastroenterol. 2015;50:856–865.
   PubMed Web of Science ®Google Scholar
• de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945–952.
   PubMed Web of Science ®Google Scholar
• Whiting JL, Sigurdsson A, Rowlands DC, et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut. 2002;50:378–381.
   PubMed Web of Science ®Google Scholar
• Vannella L, Lahner E, Osborn J, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther. 2010;31:1042–1050.
   PubMed Web of Science ®Google Scholar
• GLOBOCAN. Estimated cancer incidence, mortality and prevalence worldwide in 2012. International agency for research on cancer, World Health Organization; 2012; [cited 2014 Apr 1]. Available from: http://globocan.iarc.fr/old/factsheet.asp
   Google Scholar
• Dinis-Ribeiro M, Areia M, de Vries AC, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44:74–94.
   PubMed Web of Science ®Google Scholar
• Fang J, Liu W, Li Z, et al. Chinese consensus report on chronic gastritis. Chin J Dig. 2013;33:5–15.
   Google Scholar
• Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181.
   PubMed Web of Science ®Google Scholar
• Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. Lyon:IARC Press; 2010
   Google Scholar
• den Hoed CM, Holster IL, Capelle LG, et al. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer. Endoscopy. 2013;45:249–256.
   PubMed Web of Science ®Google Scholar
• Marques-Silva L, Areia M, Elvas L, et al. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2014;26:378–387.
   PubMed Web of Science ®Google Scholar
• Lahner E, Bordi C, Cattaruzza MS, et al. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther. 2005;22:471–481.
   PubMed Web of Science ®Google Scholar
• Cassaro M, Rugge M, Gutierrez O, et al. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000;95:1431–1438.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-González L, Wright NA. Biology of intestinal metaplasia in 2008: more than a simple phenotypic alteration. Dig Liver Dis. 2008;40:510–522.
   PubMedGoogle Scholar
• Sakitani K, Hirata Y, Watabe H, et al. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration. J Gastroenterol Hepatol. 2011;26:1570–1575.
   PubMed Web of Science ®Google Scholar
• Reddy KM, Chang JI, Shi JM, et al. Risk of gastric cancer among patients with intestinal metaplasia of the stomach in a US Integrated Health Care System. Clin Gastroenterol Hepatol. 2016;14:1420–1425.
   PubMed Web of Science ®Google Scholar
• Liu KS, Wong IO, Leung WK. Helicobacter pylori associated gastric intestinal metaplasia: treatment and surveillance. WJG. 2016;22:1311–1320.
   PubMed Web of Science ®Google Scholar
• Compare D, Rocco A, Nardone G. Screening for and surveillance of gastric cancer. World J Gastroenterol. 2014;20:13681–13691.
   PubMed Web of Science ®Google Scholar
• Ballester V, Cruz-Correa M. Endoscopic surveillance of gastrointestinal premalignant lesions. Current knowledge and future directions. Curr Opin Gastroenterol. 2014;30:477–483.
   PubMed Web of Science ®Google Scholar
• Sugano K, Tack J, Kuipers EJ, et al. Kyoto Global Consensus Conference. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353–1367.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer. Helicobacter pylori eradication as a strategy for preventing gastric cancer. IARC Working Group Reports. Vol. 8. Geneva, Switzerland: WHO Press, World Health Organization; 2014.
   Google Scholar
• Areia M, Dinis-Ribeiro M, Rocha Gonçalves F. Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions. Helicobacter. 2014;19:425–436.
   PubMed Web of Science ®Google Scholar
• Lee KS, Oh DK, Han MA, et al. Gastric cancer screening in Korea: report on the national cancer screening program in 2008. Cancer Res Treat. 2011;43:83–88.
   PubMed Web of Science ®Google Scholar
• Shin WG, Kim HU, Song HJ, et al. Surveillance strategy of atrophic gastritis and intestinal metaplasia in a country with a high prevalence of gastric cancer. Dig Dis Sci. 2012;57:746–752.
   PubMed Web of Science ®Google Scholar
• Bae JM, Shin SY, Kim EH. Mean sojourn time of preclinical gastric cancer in Korean men: a retrospective observational study. J Prev Med Public Health. 2014;47:201–205.
   PubMedGoogle Scholar
• Kim GH, Bang SJ, Ende AR, et al. Is screening and surveillance for early detection of gastric cancer needed in Korean Americans? Korean J Intern Med. 2015;30:747–758.
   PubMed Web of Science ®Google Scholar
• Park CH, Kim EH, Chung H, et al. The optimal endoscopic screening interval for detecting early gastric neoplasms. Gastrointest Endosc. 2014;80:253–259.
   PubMed Web of Science ®Google Scholar
• Nam JH, Choi IJ, Cho SJ, et al. Association of the interval between endoscopies with gastric cancer stage at diagnosis in a region of high prevalence. Cancer. 2012;118:4953–4960.
   PubMed Web of Science ®Google Scholar
• Hamashima C, Ogoshi K, Okamoto M, et al. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS One. 2013;8:e79088.
   PubMed Web of Science ®Google Scholar
• Chung SJ, Park MJ, Kang SJ, et al. Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high-incidence region of Korea. Int J Cancer. 2012;131:2376–2384.
   PubMed Web of Science ®Google Scholar